Testicular Neoplasms Clinical Trial
Official title:
Testicular Cancer and Aerobic and Strength Training - a Randomized Controlled National Phase II Study
The present study examine the effects of an aerobic and strength training program on cardiorespiratory fitness in testicular cancer (TC) patients during chemotherapy. Half of the participants will receive the exercise program and the other half will receive one individual lifestyle counseling session. The investigators hypothesize that TC patients in the exercise group will have less reduction in cardiorespiratory fitness during chemotherapy treatment compared to patients in the control group.
Testicular cancer (TC) patients receiving chemotherapy often experience troublesome
side-effects during and after treatment. Both aerobic and strength exercise have showed
beneficial effects on side-effects during and after treatment in other cancer diagnosis.
Knowledge of the effects of physical exercise during and after chemotherapy in TC patients
is insufficient and studies are needed. The primary aim is to examine the effects of
physical exercise on cardiorespiratory fitness in TC patients during chemotherapy. Secondary
aims are to examine the effects of physical exercise on other secondary health outcomes
during and three and twelve months after chemotherapy.
The present study is a randomized controlled trial comparing a tailored exercise program
consisting of aerobic and strength training during chemotherapy to a control group receiving
one individual lifestyle counseling session during the first chemotherapy cycle. The TC
patients will be included and assessed before the first cycle of chemotherapy and further
assigned to either a exercise group or a control group. The intervention will last for 9 or
12 weeks (depending on the number of bleomycin, etoposide, cisplatin (BEP)/etoposide,
cisplatin (EP) cycles received) and it will consists of two-three one-hour sessions per week
mostly supervised by a personal trainer. All variables will be assessed pre- and
post-intervention, and at three and 12 months follow-up.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00231582 -
High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II
|
Phase 2 | |
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Completed |
NCT03403777 -
Avelumab in Refractory Testicular Germ Cell Cancer.
|
Phase 2 | |
Completed |
NCT02890030 -
The Platinum Study Comparison Group
|
||
Recruiting |
NCT05264337 -
Lymphedema After Urologic Surgery
|
||
Active, not recruiting |
NCT03426865 -
Role of Axumin PET Scan in Germ Cell Tumor
|
||
Completed |
NCT00001270 -
Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
|
Phase 1 | |
Completed |
NCT02459132 -
High-Intensity Aerobic Interval Training in Testicular Cancer Survivors
|
N/A | |
Completed |
NCT06309732 -
GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)
|
Phase 2 | |
Terminated |
NCT02499952 -
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
|
Phase 2 | |
Recruiting |
NCT02304575 -
Quality of Life Among Testicular Cancer Survivors
|
N/A | |
Withdrawn |
NCT02492360 -
Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
|
N/A | |
Completed |
NCT04122430 -
Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
|
||
Recruiting |
NCT02229916 -
Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
|
||
Completed |
NCT02161692 -
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
|
Phase 2 | |
Completed |
NCT02966509 -
Engagement of Patients With Advanced Cancer
|
N/A | |
Recruiting |
NCT02341989 -
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
|
Phase 3 | |
Completed |
NCT05056688 -
Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors
|
N/A | |
Terminated |
NCT05229900 -
A Study of SGN-ALPV in Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT00123773 -
Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
|
Phase 2 |